409
Views
19
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

Molecular characterization of carbapenem- resistant Enterobacteriaceae yields increasing rates of NDM-1 carbapenemases and colistin resistance in an OXA-48- endemic area

ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon

References

  • World Health Organization (WHO). Antimicrobial resistance: global report on surveillance. 2014. Available from: http://www.who.int/drugresistance/documents/surveillancereport/en
  • Nordmann P. Carbapenemase producing Enterobactericeae: overview of a major public health challenge. Méd Maladies Infect. 2014;44:51–6.
  • Carrër A, Poirel L, Eraksoy H, Cagatay AA, Badur S, Nordmann P. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother. 2008;52(8):2950–4.
  • Carrër A, Poirel L, Yilmaz M, Akan OA, Cilli F, Cuzon G, et al. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother. 2010;54:1369–73.
  • Gulmez D, Woodford N, Palepou MF, Mushtaq S, Metan G, Yakupogullari Y, et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents. 2008;31(6):523–6.
  • Poirel L, Ozdamar M, Ocampo-Sosa AA, Turkoglu S, Ozer UG, Nordmann P. NDM-1-producing Klebsiella pneumoniae now in Turkey. Antimicrob Agents Chemother. 2012;56:2784–5.
  • Alp E, Percin D, Colakoglu S, Durmaz S, Kurkcu CA, Ekincioglu P, et al. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae in a tertiary university hospital in Turkey. J Hosp Infect. 2013;84:178–80.
  • Poirel L, Yılmaz M, Istanbullu A, Arslan F, Mert A, Bernabeu S, et al. Spread of NDM-producing Enterobactericeae in a neonatal Intensive Care Unit in Istanbul, Turkey. Antimicrob Agents Chemother. 2014;58(5):2929–33.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement. [M100–S25]. Clinical and Laboratory Standards Institute; 2015.
  • The European Committee on Antimicrobial Susceptibility Testing. EUCAST Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0. 2014. Available from: http://www.eucast.org.
  • Van Der Zwaluw K, De Haan A, Pluister GN, Bootsma HJ, De Neeling AJ, Schouls LM. The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods. PloS One. 2015;10(3):e0123690.
  • Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother. 2007;59:321–2.
  • Monteiro J, Widen RH, Pignatari ACC, Kubasek C, Silbert S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother. 2012;67:906–9.
  • Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother. 2008;52:2818–24.
  • Frasson I, Biasolo MA, Bartolini A, Cavallaro A, Richter SN, Palù G. Rapid detection of blaVIM-1-37 and blaKPC1/2-12 alleles from clinical samples bymultiplex PCR-based assays. Int J Antimicrob Agents. 2013;42(1):68–71.
  • Poirel L, Bonnin RA, Nordmann P. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother. 2012;56(1):559–62.
  • Nordmann P. OXA-163, an OXA-48-related class D β-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob Agents Chemother. 2011;55(6):2546–51.
  • Dillon B, Thomas L, Mohmand G, Zelynski A, Iredell J. Multiplex PCR for screening of integrons in bacterial lysates. J Microbiol Methods. 2005;62(2):221–32.
  • Chen J, Su Z, Liu Y, Wang S, Dai X, Li Y, et al. Identification and characterization of class 1 integrons among Pseudomonas aeruginosa isolates from patients in Zhenjiang. China. Int J Infect Dis. 2009;13:717–21.
  • Kuzucu C, Durmaz R, Otlu B, Aktas E, Gulcan H, Cizmeci Z. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey. New Microbiol. 2008;31:401–18.
  • Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17:1791–8.
  • Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikosc GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4):682–707.
  • Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48:15–22.
  • Karabay O, Altindis M, Koroglu M, Karatuna O, Aydemir ÖA, Erdem AF. The carbapenem-resistant Enterobacteriaceae threat is growing: NDM-1 epidemic at a training hospital in Turkey. Ann Clin Microbiol Antimicrob. 2016;15(1):6.
  • Bakthavatchalam YD, Anandan S, Veeraraghavan B. Laboratory detection and clinical implication of oxacillinase-48 like carbapenemase: the hidden threat. J Global Infect Dis. 2016;8:41–50.
  • Doi Y, O’Hara JA, Lando JF, Querry AM, Townsend BM, Pasculle AW, et al. Co-production of NDM-1 and OXA-232 by Klebsiella pneumoniae. Emerg Infect Dis. 2014;20(1):163–5.
  • Poirel L, Abdelaziz MO, Bernabeu S, Nordmann P. Occurrence of OXA-48 and VIM-1 carbapenemase-producing Enterobacteriaceae in Egypt. Int J Antimicrob Agents. 2013;41(1):90–1.
  • Du H, Chen L, Chavda KD, Pandey R, Zhang H, Xie X, et al. Genomic characterization of Enterobacter cloacae isolates from China that co-produce KPC-3 and NDM-1 carbapenemases. Antimicrob Agents Chemother. 2016;60(4):2519–23.
  • Mohammed Y, Zailani S, Onipede A. Characterization of KPC, NDM and VIM type carbapenem resistance Enterobacteriaceae from North Eastern. Nigeria. J Biosci Med. 2015;3:100–7.
  • Kilic A, Baysallar M. The first Klebsiella pneumoniae ısolate co-producing OXA-48 and NDM-1 in Turkey. Ann Lab Med. 2015;35(3):382–3.
  • Iraz M, Duzgun AO, Sandallı C, Doymaz MZ, Akkoyunlu Y, Saral A, et al. Distribution of β-Lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patientsin Turkey. Ann Lab Med. 2015;35:595–601.
  • Cakar A, Akyön A, Gur D, Karatuna O, Ogunc D, Baysan BO, et al. Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey. Mikrobiyol Bul. 2016;50(1):21–33.
  • Bathoorn E, Tsioutis C, Da Silva Voorham JM, Scoulica EV, Ioannidou E, Zhou K, et al. Emergence of pan-resistance in KPC-2 carbapenemase-producing Klebsiella pneumoniae in Crete, Greece: a close call. J Antimicrob Chemother. 2016;71(5):1207–12.
  • Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill. 2014;19(42). pii: 20939.
  • Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–8.
  • Hasman H, Hammerum AM, Hansen F, Hendriksen RS, Olesen B, Agersø Y, et al. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill. 2015;20(49). pii: 30085.
  • Zeng KJ, Doi Y, Patil S, Huang X, Tian GB. Emergence of plasmid-mediated mcr-1 gene in colistin-resistant Enterobacter aerogenes and Enterobacter cloacae. Antimicrob Agents Chemother. 2016;60(6):3862–3.
  • Elnahriry SS, Khalifa HO, Soliman AM, Ahmed AM, Moustafa AH, Shimamoto T, et al. Emergence of plasmid-mediated colistin resistance gene, mcr-1, in a clinical Escherichia coli isolate from Egypt. Antimicrob Agents Chemother. 2016;60(5):3249–50.
  • Mulvey MR, Mataseje LF, Robertson J, Nash JHE, Boerlin P, Toye B, et al. Dissemination of the mcr-1colistin resistance gene. The Lancet. 2016;16:289–90.
  • Kola A, Piening B, Pape UF, Veltzke-Schlieker W, Kaase M, Geffers C, et al. An outbreak of carbapenem-resistant OXA-48-producing Klebsiella pneumoniae associated to duodenoscopy. Antimicrob Resist Infect Control. 2015;4:8.
  • Seara N, Oteo J, Carrillo R, Pérez-Blanco V, Mingorance J, Gómez-Gil R, et al. Interhospital spread of NDM-7-producing Klebsiella pneumoniae belonging to ST437 in Spain. Int J Antimicrob Agents. 2015;46(2):169–73.
  • Van Duin D, Doi Y. Outbreak of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae: are we at the end of the road? J Clin Microbiol. 2015;53(10):3116–7.
  • Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18:1503–7.
  • Poirel L, Nordmann P. Rapidec Carba NP test for rapid detection of carbapenemase producers. J Clin Microbiol. 2015;53(9):3003–8.
  • Tijet N, Patel SN, Melano RG. Detection of carbapenemase activity in Enterobacteriaceae: comparison of the carbapenem inactivation method versus the Carba NP test. J Antimicrob Chemother. 2016;71(1):274–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.